Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Codexis (CDXS) Liabilities and Shareholders Equity (2016 - 2025)

Codexis (CDXS) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $147.8 million in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 0.81% year-over-year to $147.8 million; the TTM value through Dec 2025 reached $531.8 million, down 5.75%, while the annual FY2025 figure was $147.8 million, 0.81% down from the prior year.
  • Liabilities and Shareholders Equity reached $147.8 million in Q4 2025 per CDXS's latest filing, up from $124.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $250.4 million in Q4 2022 and bottomed at $121.8 million in Q1 2025.
  • Average Liabilities and Shareholders Equity over 5 years is $183.3 million, with a median of $180.6 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 64.87% in 2021, then crashed 45.46% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $246.4 million in 2021, then increased by 1.63% to $250.4 million in 2022, then plummeted by 45.46% to $136.6 million in 2023, then grew by 9.12% to $149.0 million in 2024, then dropped by 0.81% to $147.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $147.8 million in Q4 2025, $124.0 million in Q3 2025, and $138.2 million in Q2 2025.